Related Experiment Videos
Neuromuscular paralysis in the intensive care unit.
Mohammed A Al-Jumah1, Adnan A Awada, Hassan A Al-Ayafi
1Neurology Section, King Fahad National Guard Hospital, Riyadh, Kingdom of Saudi Arabia. jumahm@ngha.med.sa
Saudi Medical Journal
|April 15, 2004
Summary
Acquired neuromuscular paralysis in critically ill patients, including polyneuropathy and myopathy, is often linked to sepsis and organ failure. Steroid use is associated with myopathy, and treatment involves managing sepsis and stopping corticosteroids.
Area of Science:
- Neurology
- Critical Care Medicine
- Intensive Care Unit (ICU) Research
Background:
- Acquired neuromuscular paralysis is a significant complication in critically ill patients.
- Understanding its features, causes, and outcomes is crucial for patient management.
Purpose of the Study:
- To determine the features, causes, risk factors, and outcomes of acquired neuromuscular paralysis in critically ill patients.
- To differentiate between polyneuropathy and myopathy in the Intensive Care Unit (ICU) setting.
Main Methods:
- Retrospective review of 30 confirmed cases of acquired polyneuropathy and myopathy.
- Comprehensive electrophysiological studies and selective nerve/muscle biopsies were performed.
- Analysis of clinical data, including sepsis, multiorgan failure, and corticosteroid use.
Main Results:
- Myopathy (15 cases) was more frequent than polyneuropathy (8 cases).
- Sepsis and multiorgan failure were common risk factors for both conditions.
- High-dose steroid use was significantly associated with ICU myopathy.
Conclusions:
- Symptomatic myopathy is more prevalent than polyneuropathy in critically ill patients.
- Common risk factors include sepsis and multiorgan failure; steroid use is linked to myopathy.
- Treatment focusing on sepsis management and corticosteroid withdrawal improves outcomes.